Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Medtronic (MDT) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical DevicesMDT

Closing price · Nov 19, 2026 $100.58 -0.1% on the day · +3.6% over 12 months 52-week range $72.50 – $104.96
Get MDT alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling5last 12 months
Reported sales$14.7M3 of 18 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Dec 1, 2026 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Geoffrey Martha, CEO, Chair sold 50,000 shares at $95.00 ($4.8M).

Trade date
Oct 15, 2026
Disclosed to the SEC
Oct 16, 2026
Type
Pre-planned sale, 10b5-1 (code S)

Read the original SEC filing ↗All MDT insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

MDT insider transactions (Form 4)

Open-market purchases and sales. 64 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Oct 16SEC Geoffrey MarthaCEO, Chair Sell Plan 50,000277,866 held (−15%) $95.00 $4.8M +5.9% —
Oct 16SEC Michael MarinaroEvp, Pres Medsurg And Americas Sell Plan 10,420105,916 held (−9%) $96.00 $1.0M +4.8% —
Sep 17SEC Harry Skip KiilPresident Sell 1,48342,186 held (−3%) $93.65 $139K +7.4% —
Jul 9SEC Matthew R. WalterSvp, Chief Hr Officer Sell Plan 3,10235,694 held (−8%) $83.15 $258K +21.0% —
Jun 9SEC Harry Skip KiilPresident Sell 3,96137,455 held (−10%) $80.44 $319K +25.0% —
Jun 9SEC Harry Skip KiilPresident Sell 22837,227 held (−1%) $80.45 $18K +25.0% —
Feb 26SEC Harry Skip KiilPresident Sell 30,56853,076 held (−37%) $97.66 $3.0M +3.0% —
Feb 26SEC Harry Skip KiilPresident Sell 19,25533,821 held (−36%) $97.77 $1.9M +2.9% —
Feb 26SEC Harry Skip KiilPresident Sell 1,64883,644 held (−2%) $97.86 $161K +2.8% —
Feb 26SEC Harry Skip KiilPresident Sell 66833,153 held (−2%) $97.83 $65K +2.8% —
Feb 26SEC Harry Skip KiilPresident Sell 38532,768 held (−1%) $97.82 $38K +2.8% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 24,18651,830 held (−32%) $101.93 $2.5M -1.3% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 1,99547,893 held (−4%) $102.03 $204K -1.4% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 1,94249,888 held (−4%) $101.99 $198K -1.4% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 82547,068 held (−2%) $102.04 $84K -1.4% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 50046,016 held (−1%) $102.08 $51K -1.5% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 32546,516 held (−1%) $102.06 $33K -1.5% —
Nov 21SEC Gregory L. SmithEvp Global Ops & Supply Chain Sell 22746,841 held (−0%) $102.05 $23K -1.4% —
Historical context

Similar past setups: not applicable. MDT has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with MDT in the Research Lab

MDT has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

MDT closeInsider buyInsider sale
708090100110DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-17EEarnings release filed 2026-06-03EEarnings release filed 2026-09-01Sold $138,883 on 2026-09-16 · Harry Skip KiilSold $257,931 on 2026-07-08 · Matthew R. WalterSold $336,965 on 2026-06-08 · Harry Skip KiilSold $3,058,451 on 2025-11-19 · Gregory L. SmithSold $5,132,217 on 2026-02-19 · Harry Skip KiilSold $5,750,320 on 2026-10-15 · Geoffrey Martha, Michael Marinaro
Bought, 12 months$0
Sold, 12 months$14.7M
Insiders buying0
Insiders selling5

Medtronic insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $14.7M of MDT stock on the open market; P/E 21.6 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

MDT insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $3.1M sold (7 trades)Q4 2025Q1 2026: $5.1M sold (5 trades)Q1 2026Q2 2026: $337K sold (2 trades)Q2 2026Q3 2026: $397K sold (2 trades)Q3 2026Q4 2026: $5.8M sold (2 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$5.8M2
Q3 2026—0$397K2
Q2 2026—0$337K2
Q1 2026—0$5.1M5
Q4 2025—0$3.1M7

Valuation, profit and volume

P/E (trailing)21.6Sector median 25.0
Market value$112.53BMedical Devices
Profit margin13.9%Revenue growth +13.7%
Volume vs. 50-day0.3×Last 5 sessions

Source: Yahoo Finance, as of Oct 5, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Medtronic insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $14.7M. 3 of 18 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

MDT earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Sep 1, 2026 -0.7% None +1.7%S&P -0.2% -5.5%
Jun 3, 2026 -4.6% None +11.1%S&P -0.3% +2.5%
Feb 17, 2026 -1.5% None -1.0%S&P +0.7% -12.5%
Nov 18, 2025 +6.2% None +4.2%S&P -0.5% -1.7%
Aug 19, 2025 +3.9% None +0.4%S&P -0.8% +2.0%
May 21, 2025 +3.5% None -6.3%S&P -1.6% +6.7%
Feb 18, 2025 +0.9% None -6.3%S&P +0.5% +3.8%
Nov 19, 2024 -2.8% None -4.0%S&P +0.4% -3.7%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

MDT short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 30% of volume sold short2026-08-27: 42% of volume sold short2026-08-28: 33% of volume sold short2026-08-31: 34% of volume sold short2026-09-01: 38% of volume sold short2026-09-02: 45% of volume sold short2026-09-03: 48% of volume sold short2026-09-04: 46% of volume sold short2026-09-08: 40% of volume sold short2026-09-09: 31% of volume sold short2026-09-10: 43% of volume sold short2026-09-11: 43% of volume sold short2026-09-14: 37% of volume sold short2026-09-15: 49% of volume sold short2026-09-16: 51% of volume sold short2026-09-17: 52% of volume sold short2026-09-18: 40% of volume sold short2026-09-21: 43% of volume sold short2026-09-22: 26% of volume sold short2026-09-23: 43% of volume sold short2026-09-24: 53% of volume sold short2026-09-25: 49% of volume sold short2026-09-28: 68% of volume sold short2026-09-29: 34% of volume sold short2026-09-30: 58% of volume sold short2026-10-01: 43% of volume sold short2026-10-02: 67% of volume sold short2026-10-05: 85% of volume sold short2026-10-06: 71% of volume sold short2026-10-07: 53% of volume sold short2026-10-08: 74% of volume sold short2026-10-09: 73% of volume sold short2026-10-12: 64% of volume sold short2026-10-13: 47% of volume sold short2026-10-14: 50% of volume sold short2026-10-15: 42% of volume sold short2026-10-16: 45% of volume sold short2026-10-19: 42% of volume sold short2026-10-20: 52% of volume sold short2026-10-21: 54% of volume sold short2026-10-22: 39% of volume sold short2026-10-23: 42% of volume sold short2026-10-26: 55% of volume sold short2026-10-27: 37% of volume sold short2026-10-28: 42% of volume sold short2026-10-29: 40% of volume sold short2026-10-30: 51% of volume sold short2026-11-02: 52% of volume sold short2026-11-03: 39% of volume sold short2026-11-04: 38% of volume sold short2026-11-05: 46% of volume sold short2026-11-06: 31% of volume sold short2026-11-09: 31% of volume sold short2026-11-10: 39% of volume sold short2026-11-11: 36% of volume sold short2026-11-12: 38% of volume sold short2026-11-13: 41% of volume sold short2026-11-16: 34% of volume sold short2026-11-17: 29% of volume sold short2026-11-18: 32% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 32%20-day average: 40%Prior 2 months: 56%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded MDT

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Thomas H TubervilleSenate Sold $15,001 - $50,000 Aug 26, 2024Aug 5, 2026 +21.1%
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +17.4%

Insiders at Medtronic

InsiderBoughtSoldLast filingPast buys beat S&PScore
Harry Skip KiilPresident — $5.6M Sep 17, 2026 — —
Geoffrey MarthaCEO, Chair — $4.8M Oct 16, 2026 — —
Gregory L. SmithEvp Global Ops & Supply Chain — $3.1M Nov 21, 2025 — —
Michael MarinaroPresident — $1.0M Nov 4, 2026 — —
Matthew R. WalterSvp, Chief Hr Officer — $258K Aug 4, 2026 — —
Kevin E. LoftonDirector — — Oct 21, 2026 — —
Denise L. BlomquistChief Accounting Officer — — Sep 16, 2026 — —
Kweli ThompsonPresident — — Aug 4, 2026 — —
Michelle QuinnEvp, Gc And Secretary — — Aug 4, 2026 — —
Thierry PietonCFO — — Aug 4, 2026 — —
Brett A. WallEvp & Pres Neuroscience — — May 28, 2026 — —
Craig ArnoldDirector — — Apr 29, 2026 — —
Randall J. HoganDirector — — Apr 29, 2026 — —
Scott C. DonnellyDirector — — Apr 29, 2026 — —
Kendall J. PowellDirector — — Apr 29, 2026 — —
Lidia FonsecaDirector — — Apr 29, 2026 — —
Elizabeth G. NabelDirector — — Apr 29, 2026 — —
Gregory P. LewisDirector — — Apr 29, 2026 — —
William R. JellisonDirector — — Apr 29, 2026 — —
John P. GroetelaarsDirector — — Apr 29, 2026 — —
Joon Sup LeeDirector — — Apr 29, 2026 — —

Board links: companies that share insiders with MDT

Directors and executives who filed Form 4s for MDT and another company in the last 12 months.

See the map →
  • HONHoneywell Technologies Craig Arnold Director here · Director at HON · latest filing Apr 29, 2026
  • HONAHoneywell Aerospace Craig Arnold Director here · Director at HONA · latest filing Sep 3, 2026
  • KGSKodiak Gas Services Randall J. Hogan Director here · Director at KGS · latest filing Nov 18, 2026
  • KKRKKR Craig Arnold Director here · Director at KKR · latest filing Apr 29, 2026
  • MRNAModerna Elizabeth G. Nabel Director here · Director at MRNA · latest filing May 4, 2026
  • NEENextEra Energy Geoffrey Martha CEO, Chair here · Director at NEE · latest filing Oct 16, 2026
  • PFEPfizer Lidia Fonseca Director here · President at PFE · latest filing Apr 29, 2026
  • PGProcter & Gamble Craig Arnold Director here · Director at PG · latest filing Oct 14, 2026
  • TXTTextron Scott C. Donnelly Director here · Chair at TXT · latest filing Apr 29, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

MDT stock: common questions

Are Medtronic insiders buying MDT stock?

No. No Medtronic insider reported an open-market purchase of MDT in the past 12 months.

Are Medtronic insiders selling MDT stock?

5 insiders reported sales worth $14.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is MDT's P/E ratio?

MDT trades at about 21.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is MDT's 52-week range?

Over the past year MDT has traded between $72.50 and $104.96. It last closed at $100.58 on Nov 19, 2026.